droxidopa has been researched along with Ophthalmoplegia, Progressive Supranuclear in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ota, S; Tsuchiya, K | 1 |
| Fujii, S; Hatanaka, Y; Yamamoto, M | 1 |
| Maruyama, T; Tamaru, F; Yamagisawa, N | 1 |
| Kinoshita, I; Kishikawa, M; Matsuo, H; Mori, M; Nagataki, S; Takashima, H; Tsujihata, M | 1 |
4 other study(ies) available for droxidopa and Ophthalmoplegia, Progressive Supranuclear
| Article | Year |
|---|---|
[Pure akinesia presenting with antecollis].
Topics: Aged; Droxidopa; Dystonia; Female; Humans; Movement Disorders; Parkinson Disease; Supranuclear Palsy, Progressive | 2005 |
Result of long-term administration of L-threo-3,4-dihydroxyphenylserine in patients with pure akinesia as an early symptom of progressive supranuclear palsy.
Topics: Antiparkinson Agents; Droxidopa; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Supranuclear Palsy, Progressive | 1997 |
[A case of progressive supranuclear palsy dramatically improved with L-threo-3,4-dihydroxyphenylserine].
Topics: Aged; Droxidopa; Female; Frontal Lobe; Humans; Norepinephrine; Supranuclear Palsy, Progressive | 1992 |
Pure akinesia: an atypical manifestation of progressive supranuclear palsy.
Topics: Aged; Brain; Droxidopa; Female; Gait; Gliosis; Humans; Magnetic Resonance Imaging; Middle Aged; Movement Disorders; Neurofibrils; Norepinephrine; Organ Size; Parkinson Disease; Substantia Nigra; Supranuclear Palsy, Progressive | 1991 |